Irbesartan Tablet
Product Images NDC 65862-639

10 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 65862-639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Placebo-subtracted Reduction In Trough Sesbp; Integrated Analysis (Irbesartan Fig1)

Figure 1. Placebo-subtracted Reduction In Trough Sesbp; Integrated Analysis (Irbesartan Fig1)
A scatter plot with a fitted curve showing the relationship between irbesartan dose (mg/day) on the x-axis and reduction in systolic blood pressure (mmHg) on the y-axis. The graph illustrates data points and a dose-response curve for irbesartan's effect on blood pressure reduction.*
FDA Label Image

Figure 1. Placebo-subtracted Reduction In Trough Sedbp; Integrated Analysis (Irbesartan Fig2)

Figure 1. Placebo-subtracted Reduction In Trough Sedbp; Integrated Analysis (Irbesartan Fig2)
A scatter plot with a fitted curve showing the relationship between Irbesartan dose (mg/day) on the x-axis and placebo-subtracted reduction in trough SeDBP (mmHg) on the y-axis. The graph illustrates how the reduction in SeDBP changes with increasing doses of Irbesartan up to 900 mg/day.*
FDA Label Image

Figure 3 (Irbesartan Fig3)

Figure 3 (Irbesartan Fig3)
Kaplan-Meier curve showing cumulative event rate percentage over months of follow-up for Irbesartan, Amlodipine, and Placebo groups. The chart compares primary endpoint outcomes related to serum creatinine doubling, end-stage renal disease, or all-cause mortality. A small inset presents relative risk (RR) and p-values for Irbesartan versus Placebo and Amlodipine.*
FDA Label Image

Package Label-principal Display Panel (75 mg (90 Tablet Bottle))

Package Label-principal Display Panel (75 mg (90 Tablet Bottle))
Label for Irbesartan Tablets USP 75 mg by Aurobindo Pharma Limited. The label indicates the product is for prescription use only and contains 90 tablets. It includes storage instructions, distributor information for Aurobindo Pharma USA, and dosage reference to the package insert. The label is marked for overprinting and coding areas.*
FDA Label Image

Package Label-principal Display Panel -75 mg Blister Carton(10 X 10 Unit-dose) (Irbesartan Fig5)

Package Label-principal Display Panel -75 mg Blister Carton(10 X 10 Unit-dose) (Irbesartan Fig5)
Carton label for Irbesartan Tablets USP 75 mg by Aurobindo Pharma Limited. The label shows a package of 100 tablets (10 x 10 unit-dose). The front panel includes strength, drug name, and Rx only statement, along with the NDC 65862-637-78 and distributor details for Aurobindo Pharma USA, Inc. The carton also provides storage instructions and dosage information references.*
FDA Label Image

Package Label-principal Display Panel- 150 mg (90 Tablet Bottle) (Irbesartan Fig6)

Package Label-principal Display Panel- 150 mg (90 Tablet Bottle) (Irbesartan Fig6)
Label for Irbesartan Tablets USP 150 mg by Aurobindo Pharma Limited. The label states Rx only and indicates the package contains 90 tablets. It includes storage instructions, distributor information for Aurobindo Pharma USA, Inc., and a barcode. The product is made in India.*
FDA Label Image

Package Label-principal Display Panel -150 mg Blister Carton(10 X 10 Unit-dose) (Irbesartan Fig7)

Package Label-principal Display Panel -150 mg Blister Carton(10 X 10 Unit-dose) (Irbesartan Fig7)
Packaging label for Irbesartan Tablets, USP 150 mg tablets by Aurobindo Pharma Limited. The label indicates a prescription drug with 100 tablets per package, arranged as 10 x 10 unit-dose. It includes storage instructions and a barcode. The label also shows distribution information for Aurobindo Pharma USA, Inc., with the product made in India.*
FDA Label Image

Package Label-principal Display Panel (300 mg (90 Tablet Bottle))

Package Label-principal Display Panel (300 mg (90 Tablet Bottle))
Label for Irbesartan Tablets, USP 300 mg, a drug for further processing by Aurobindo Pharma Limited. The label includes dosage strength, quantity of 90 tablets, storage instructions at 20° to 25°C, and distributor information for Aurobindo Pharma USA, Inc. with address in East Windsor, NJ. The NDC is 65862-639-90.*
FDA Label Image

Package Label-principal Display Panel (300 mg (90 Tablet Bottle))

Package Label-principal Display Panel (300 mg (90 Tablet Bottle))
Packaging label for Irbesartan Tablets, USP 300 mg by Aurobindo Pharma Limited. The label indicates 100 tablets in a 10 x 10 unit-dose package. The label includes storage instructions, dosage information reference, and states the product is Rx only. Distributed by Aurobindo Pharma USA, Inc., made in India, with NDC 65862-639-78.*
FDA Label Image

Structure (Irbesartan Str)

Structure (Irbesartan Str)
Chemical structure diagram of Irbesartan, showing its molecular framework including a tetrazole ring, biphenyl group, and cyclopentane moiety with attached functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.